(Bloomberg) — Global stock markets are on the cusp of finishing a record-breaking month sparked by major progress toward a coronavirus vaccine.
Trading was muted on Monday, with European stocks holding steady and U.S. futures slightly lower. The MSCI World Index has soared 13% in November, the best performance on record.
“I suspect that investors have become cautious after big gains in the last few weeks that were driven by the vaccine news,” said Peter Rosenstreich, head of market strategy at Swissquote Bank. “It’s a big positive as it’s really provided an endgame for Covid-19.”
Value Rotation Gives Europe a $1.7 Trillion Boost: Taking Stock
Over the weekend, U.S. Surgeon General Jerome Adams said the federal government hopes to quickly review and approve requests from two drugmakers for emergency approval of their Covid-19 vaccines.
The rapid pace to a vaccine has given investors